Oncolytics Biotech
ONCY
#9265
Rank
โ‚น9.01 B
Marketcap
โ‚น84.96
Share price
-4.78%
Change (1 day)
14.03%
Change (1 year)

Oncolytics Biotech (ONCY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น0.96 Billion

According to Oncolytics Biotech 's latest financial reports the company's total liabilities are โ‚น0.96 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oncolytics Biotech - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น0.84 B20.18%
2023-12-31โ‚น0.70 B6.96%
2022-12-31โ‚น0.66 B15.64%
2021-12-31โ‚น0.57 B3.82%
2020-12-31โ‚น0.55 B-49.02%
2019-12-31โ‚น1.07 B142.5%
2018-12-31โ‚น0.44 B-11.19%
2017-12-31โ‚น0.50 B143.55%
2016-12-31โ‚น0.20 B58.51%
2015-12-31โ‚น0.12 B-29.56%
2014-12-31โ‚น0.18 B-47.16%
2013-12-31โ‚น0.34 B-13.14%
2012-12-31โ‚น0.40 B18.69%
2011-12-31โ‚น0.33 B201.74%
2010-12-31โ‚น0.11 B-39.86%
2009-12-31โ‚น0.18 B4%
2008-12-31โ‚น0.17 B61.49%
2007-12-31โ‚น0.11 B5.46%
2006-12-31โ‚น0.10 B47.77%
2005-12-31โ‚น71.21 M79.67%
2004-12-31โ‚น39.63 M9.12%
2003-12-31โ‚น36.32 M-15.17%
2002-12-31โ‚น42.81 M-54.67%
2001-12-31โ‚น94.46 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Aeterna Zentaris
AEZS
โ‚น2.14 B 121.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น8.191 T 848,659.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น7.040 T 729,425.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น2.931 T 303,697.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
โ‚น6.51 B 574.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
โ‚น16.47 B 1,607.52%๐Ÿ‡บ๐Ÿ‡ธ USA